Literature DB >> 12885715

Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants.

Hylco Bouwstra1, D A Janneke Dijck-Brouwer, Jacqueline A L Wildeman, Hendrika M Tjoonk, Jolanda C van der Heide, E Rudy Boersma, Frits A J Muskiet, Mijna Hadders-Algra.   

Abstract

BACKGROUND: Whether long-chain polyunsaturated fatty acids (LCPs) play a role in the development of the young nervous system in term infants is debated.
OBJECTIVE: We investigated whether supplementation of formula with LCPs for 2 mo improves the quality of general movements (GMs) in healthy term infants at 3 mo of age.
DESIGN: A prospective, double-blind, randomized controlled study was conducted with 2 groups of healthy term infants: a control-formula (CF) group (n = 131) and an LCP-supplemented-formula (LF) group (n = 119). A breastfed (BF) group (n = 147) served as a reference. Information on potential confounders was collected at enrollment. Videotapes were made of the infants' spontaneous motor behavior at 3 mo of age to assess the quality of their GMs. On the basis of quality, normal GMs were classified as normal-optimal or normal-suboptimal, and abnormal GMs were classified as mildly or definitely abnormal. Attrition at 3 mo of age was 15% and nonselective. Multivariate regression analyses with adjustment for confounders were carried out to evaluate the effect of the type of feeding.
RESULTS: None of the infants had definitely abnormal GMs. Infants in the CF group had mildly abnormal GMs significantly more often than did infants in the LF and BF groups (31% compared with 19% and 20%, respectively). Infants in the BF group had normal-optimal GMs more frequently than did infants in the LF and CF groups (34% compared with 18% and 21%, respectively). Logistic regression analyses confirmed these findings.
CONCLUSION: Supplementation of healthy term infants with LCPs during the first 2 mo of life reduces the occurrence of mildly abnormal GMs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885715     DOI: 10.1093/ajcn/78.2.313

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Near-infrared spectroscopy and partial least-squares regression for determination of arachidonic acid in powdered oil.

Authors:  Meiyan Yang; Shaoping Nie; Jing Li; Mingyong Xie; Hua Xiong; Zeyuan Deng; Weiwan Zheng; Lin Li; Xiaoming Zhang
Journal:  Lipids       Date:  2010-05-14       Impact factor: 1.880

2.  The effect of perinatal fish oil supplementation on neurodevelopment and growth of infants: a randomized controlled trial.

Authors:  Alireza Ostadrahimi; Hanieh Salehi-Pourmehr; Sakineh Mohammad-Alizadeh-Charandabi; Seifollah Heidarabady; Azizeh Farshbaf-Khalili
Journal:  Eur J Nutr       Date:  2017-07-27       Impact factor: 5.614

Review 3.  Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.

Authors:  Tim Schindler; John Kh Sinn; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2016-10-28

Review 4.  Infant formula and neurocognitive outcomes: impact of study end-point selection.

Authors:  H Sun; P G Como; L C Downey; D Murphy; R L Ariagno; W Rodriguez
Journal:  J Perinatol       Date:  2015-08-06       Impact factor: 2.521

Review 5.  Effect of long-chain polyunsaturated fatty acid supplementation on neurodevelopmental outcome in full-term infants.

Authors:  Mijna Hadders-Algra
Journal:  Nutrients       Date:  2010-07-27       Impact factor: 5.717

6.  Oral consumption of α-linolenic acid increases serum BDNF levels in healthy adult humans.

Authors:  Mahmoudreza Hadjighassem; Behnam Kamalidehghan; Nima Shekarriz; Argavan Baseerat; Nima Molavi; Masoud Mehrpour; Mohammad Taghi Joghataei; Mahdi Tondar; Fatemeh Ahmadipour; Goh Yong Meng
Journal:  Nutr J       Date:  2015-02-26       Impact factor: 3.271

7.  Effect of long-chain polyunsaturated fatty acids in infant formula on long-term cognitive function in childhood: A systematic review and meta-analysis of randomised controlled trials.

Authors:  Maximiliane L Verfuerden; Sarah Dib; John Jerrim; Mary Fewtrell; Ruth E Gilbert
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

8.  Atypical general movements in the general population: Prevalence over the last 15 years and associated factors.

Authors:  Ying-Chin Wu; Hylco Bouwstra; Kirsten R Heineman; Mijna Hadders-Algra
Journal:  Acta Paediatr       Date:  2020-05-13       Impact factor: 2.299

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.